Results 131 to 140 of about 977 (156)

B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome

Nature Reviews Clinical Oncology, 2022
Wolf H Fridman, Maxime Meylan, Florent Petitprez   +2 more
exaly  

Tumour burden and efficacy of immune-checkpoint inhibitors

Nature Reviews Clinical Oncology, 2021
Aurelien Marabelle, Camilo Garcia, Mihaela Aldea   +2 more
exaly  

Pindborg Tumour: A Rare Odontogenic Neoplasm

The Internet Journal of Dental Science, 2008
openaire   +1 more source

Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire

Nature Reviews Clinical Oncology, 2020
Sebastian P Haen, Markus W Löffler, Hans-Georg Rammensee   +2 more
exaly  

Calcifying epithelial odontogenic tumour (Pindborg tumour) in Indians.

Indian journal of cancer, 1969
V M, Doctor, M V, Sirsat
openaire   +1 more source

Neutrophil diversity and plasticity in tumour progression and therapy

Nature Reviews Cancer, 2020
Sebastien Jaillon, Andrea Ponzetta, Diletta Di Mitri   +2 more
exaly  

Tumour-associated macrophages as treatment targets in oncology

Nature Reviews Clinical Oncology, 2017
Alberto Mantovani, Federica Marchesi, Alberto Malesci   +2 more
exaly  

Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape

Nature Reviews Clinical Oncology, 2016
Sabine Riethdorf, Klaus Pantel
exaly  

The functions and regulation of the PTEN tumour suppressor: new modes and prospects

Nature Reviews Molecular Cell Biology, 2018
Yu-Ru Lee, Ming Chen, Pier Paolo Pandolfi   +2 more
exaly  

Tumour heterogeneity and resistance to cancer therapies

Nature Reviews Clinical Oncology, 2017
Ibiayi Dagogo-Jack
exaly